Flameret begins shipping high CBD hemp oil orders
Company plans to introduce second Cannabidiol product within days
Flameret's Colorado-based subsidiary Royal Hemp Corporation, has begun shipping orders of Cannadol, its high CBD (cannabidiol) hemp oil. In the first three days following the product launch announcement, the company received orders from 21 different customers.
Cannadol is a dietary supplement sold as a hemp oil rich in CBD. It consists of 200mg of cannabidiol cold pressed from industrial hemp in an oral suspension of 1 ounce of hemp oil. Scientific and clinical studies continue to underscore CBD's potential as a possible treatment for a wide range of conditions, including rheumatoid arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrated neuroprotective and neurogenic capabilities, and its anticancer properties are currently being investigated at several academic research centres in the US and elsewhere.
'The launch of Cannadol and the response from consumers has far surpassed our internal expectations,' said John Meredith, Chief Executive Officer of Flameret. The company is also in the process of launching a new line of products derived from industrial hemp which will be marketed and sold through Royal Hemp Corporation.
